Harfst & Associates’s Cintas CTAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$294K Sell
1,506
-72
-5% -$14.3K 0.04% 101
2026
Q2
$268K Sell
1,578
-1,288
-45% -$223K 0.04% 107
2026
Q1
$485K Sell
2,866
-4,902
-63% -$940K 0.09% 101
2025
Q4
$1.46M Sell
7,768
-135
-2% -$25.4K 0.26% 71
2025
Q3
$1.62M Buy
7,903
+98
+1% +$20.9K 0.3% 63
2025
Q2
$1.74M Buy
7,805
+4,411
+130% +$949K 0.36% 50
2025
Q1
$698K Buy
+3,394
New +$676K 0.16% 73

Other funds holding CTAS

Harfst & Associates's CTAS Position: Q3 2026 in Review

Harfst & Associates reduced its Cintas (CTAS) stake by 4.6% in Q3 2026, selling an estimated $14.3K and leaving 1,506 shares worth $294K. The position accounts for 0.04% of the portfolio, ranked #101.

Harfst & Associates first reported a position in CTAS in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.74M in Q2 2025. 326 funds tracked by Wall St. Rank hold CTAS as of Q3 2026.

  • Harfst & Associates held 1,506 shares of Cintas worth $294K as of Q3 2026.
  • Harfst & Associates sold 72 Cintas shares in Q3 2026, an estimated $14.3K.
  • Cintas made up 0.04% of Harfst & Associates's portfolio in Q3 2026, its #101 holding.
  • Harfst & Associates first reported a position in Cintas in Q1 2025 and has held it in 7 quarters since.
  • Harfst & Associates's Cintas position peaked at $1.74M in Q2 2025.
  • 326 funds tracked by Wall St. Rank held Cintas as of Q3 2026.

Based on Harfst & Associates's 13F filing for Q3 2026, filed 20 Oct 2026.